These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25555447)

  • 1. Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma.
    Costa LJ; Huang JX; Hari PN
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):701-6. PubMed ID: 25555447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
    Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
    Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.
    Auner HW; Szydlo R; Hoek J; Goldschmidt H; Stoppa AM; Morgan GJ; Moreau P; Attal M; Marit G; Russell N; Brune M; Cook G; Sonneveld P; Schönland S; Garderet L; Kröger N
    Bone Marrow Transplant; 2015 Feb; 50(2):209-15. PubMed ID: 25387088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
    Munshi PN; Vesole DH; St Martin A; Davila O; Kumar S; Qazilbash M; Shah N; Hari PN; D'Souza A
    Cancer; 2021 Nov; 127(22):4233-4239. PubMed ID: 34374445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.
    Ailawadhi S; Adu Y; Frank RD; Das S; Hodge DO; Fernandez A; Flott C; Elliott J; Parrondo R; Sher T; Roy V; Chanan-Khan AA
    Blood Cancer J; 2024 May; 14(1):86. PubMed ID: 38806475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.
    Auner HW; Garderet L; Kröger N
    Br J Haematol; 2015 Nov; 171(4):453-62. PubMed ID: 26213240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant Nationwide Variability in the Costs and Hospital Mortality Rates of Autologous Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample Database.
    Liu Y; Han H; Shah G; Giralt S; Ola Landgren C; He J; Lesokhin AM
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):41-46. PubMed ID: 30195073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents.
    Al-Hamadani M; Hashmi SK; Go RS
    Am J Hematol; 2014 Aug; 89(8):825-30. PubMed ID: 24799343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.
    Fiala MA; Finney JD; Stockerl-Goldstein KE; Tomasson MH; DiPersio JF; Vij R; Wildes TM
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1153-4. PubMed ID: 25771403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
    Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
    Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
    Hari PN; Majhail NS; Zhang MJ; Hassebroek A; Siddiqui F; Ballen K; Bashey A; Bird J; Freytes CO; Gibson J; Hale G; Holmberg L; Kamble R; Kyle RA; Lazarus HM; LeMaistre CF; Loberiza F; Maiolino A; McCarthy PL; Milone G; Omondi N; Reece DE; Seftel M; Trigg M; Vesole D; Weiss B; Wiernik P; Lee SJ; Rizzo JD; Mehta P
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):395-402. PubMed ID: 19922808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary malignancy after multiple myeloma-population trends and cause-specific mortality.
    Costa LJ; Godby KN; Chhabra S; Cornell RF; Hari P; Bhatia S
    Br J Haematol; 2018 Aug; 182(4):513-520. PubMed ID: 29974936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis.
    Mahindra A; Hari P; Fraser R; Fei M; Huang J; Berdeja J; Callander N; Costa L; Diaz MA; Freytes C; Gale RP; Girnius S; Holmberg L; Kharfan-Dabaja M; Kumar S; Kyle R; Lazarus H; Lee C; Maiolino A; Moreb J; Nishihori T; Pawarode A; Saad A; Savani BN; Schriber J; William B; Wirk BM; Krishnan A; Nieto Y; D'Souza A
    Bone Marrow Transplant; 2017 Dec; 52(12):1616-1622. PubMed ID: 28920949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
    Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
    Kumar SK; Dispenzieri A; Fraser R; Mingwei F; Akpek G; Cornell R; Kharfan-Dabaja M; Freytes C; Hashmi S; Hildebrandt G; Holmberg L; Kyle R; Lazarus H; Lee C; Mikhael J; Nishihori T; Tay J; Usmani S; Vesole D; Vij R; Wirk B; Krishnan A; Gasparetto C; Mark T; Nieto Y; Hari P; D'Souza A
    Leukemia; 2018 Apr; 32(4):986-995. PubMed ID: 29263438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Kumar A; Kharfan-Dabaja MA; Glasmacher A; Djulbegovic B
    J Natl Cancer Inst; 2009 Jan; 101(2):100-6. PubMed ID: 19141779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older patients with myeloma derive similar benefit from autologous transplantation.
    Sharma M; Zhang MJ; Zhong X; Abidi MH; Akpek G; Bacher U; Callander NS; Dispenzieri A; Freytes CO; Fung HC; Gale RP; Gasparetto C; Gibson J; Holmberg LA; Kindwall-Keller TL; Klumpp TR; Krishnan AY; Landau HJ; Lazarus HM; Lonial S; Maiolino A; Marks DI; Mehta P; Mikhael Med JR; Nishihori T; Olsson R; Ramanathan M; Roy V; Savani BN; Schouten HC; Scott E; Tay J; To LB; Vesole DH; Vogl DT; Hari P
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1796-803. PubMed ID: 25046833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.
    Oke O; Sethi T; Goodman S; Phillips S; Decker I; Rubinstein S; Concepcion B; Horst S; Jagasia M; Kassim A; Harrell SL; Langone A; Lenihan D; Rawling KT; Slosky D; Cornell RF
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1473-1477. PubMed ID: 28546074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.